Funding for this research was provided by:
National Health and Medical Research Council (APP1020607)
Received: 18 November 2018
Accepted: 23 June 2019
First Online: 4 July 2019
Ethics approval and consent to participate
: The ET300 DENV strain was received from researchers associated to University of Queensland (UQ) and Queensland Health, Australia. Patient data were anonymized by QH while IRB approval was obtained from UQ. Ethical approval for the research was obtained via The Monash University Human Research Ethics Committee (permit CF11/0766–2011000387). Adult human volunteer blood feeders agreed upon written informed consent prior to the study. No data were collected on these individuals.
: Not applicable.
: The authors declare that they have no competing interests.